The levels of MXD1 mRNA transcripts ranked the lowest in colorectal cancer (13 studies), leukemia (8 studies), esophageal cancer (5 studies) and head and neck cancer (4 studies) (Fig. S3I–N). Here, MXD1 is linked to leukemia.